Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G B Patel

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Vaccine|September 1, 1995
Recombinant gp160 vaccination schedule and MHC HLA type as factors influencing cellular responses to HIV-1 envelope glycoprotein. NIAID AIDS Vaccine Clinical Trials NetworkG J Gorse, G B Patel, F K Newman, et al.
Archives of Microbiology|January 1, 1989
Identification of three distinct Clostridium thermocellum xylanase genes by molecular cloningC R MacKenzie, R C Yang, G B Patel, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 1, 2008
Inhibition of airway eosinophilia and pulmonary pathology in a mouse model of allergic asthma by the live vaccine strain of Francisella tularensisR KuoLee, H Zhou, G Harris, et al.
Vaccine|February 13, 2001
Cytokine responses to human immunodeficiency virus type 1 (HIV-1) induced by immunization with live recombinant canarypox virus vaccine expressing HIV-1 genes boosted by HIV-1(SF-2) recombinant GP120G J Gorse, G B Patel, M D Mandava, et al.
Biochimica Et Biophysica Acta|October 16, 1999
A structural comparison of the total polar lipids from the human archaea Methanobrevibacter smithii and Methanosphaera stadtmanae and its relevance to the adjuvant activities of their liposomesG D Sprott, J Brisson, C J Dicaire, et al.
Vaccine|February 1, 1995
HIV-1 recombinant gp160 vaccine induced antibodies in serum and saliva. The NIAID AIDS Vaccine Clinical Trials NetworkG J Gorse, J H Rogers, J E Perry, et al.
Clinical and Diagnostic Laboratory Immunology|July 1, 1996
Antibody to native human immunodeficiency virus type 1 envelope glycoproteins induced by IIIB and MN recombinant gp120 vaccines. The NIAID AIDS Vaccine Evaluation GroupG J Gorse, G B Patel, F K Newman, et al.
AIDS Research and Human Retroviruses|February 24, 1999
HIV-1MN recombinant glycoprotein 160 vaccine-induced cellular and humoral immunity boosted by HIV-1MN recombinant glycoprotein 120 vaccine. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation GroupG J Gorse, L Corey, G B Patel, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Vaccine|September 1, 1995
Recombinant gp160 vaccination schedule and MHC HLA type as factors influencing cellular responses to HIV-1 envelope glycoprotein. NIAID AIDS Vaccine Clinical Trials NetworkG J Gorse, G B Patel, F K Newman, et al.
Archives of Microbiology|January 1, 1989
Identification of three distinct Clostridium thermocellum xylanase genes by molecular cloningC R MacKenzie, R C Yang, G B Patel, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 1, 2008
Inhibition of airway eosinophilia and pulmonary pathology in a mouse model of allergic asthma by the live vaccine strain of Francisella tularensisR KuoLee, H Zhou, G Harris, et al.
Vaccine|February 13, 2001
Cytokine responses to human immunodeficiency virus type 1 (HIV-1) induced by immunization with live recombinant canarypox virus vaccine expressing HIV-1 genes boosted by HIV-1(SF-2) recombinant GP120G J Gorse, G B Patel, M D Mandava, et al.
Biochimica Et Biophysica Acta|October 16, 1999
A structural comparison of the total polar lipids from the human archaea Methanobrevibacter smithii and Methanosphaera stadtmanae and its relevance to the adjuvant activities of their liposomesG D Sprott, J Brisson, C J Dicaire, et al.
Vaccine|February 1, 1995
HIV-1 recombinant gp160 vaccine induced antibodies in serum and saliva. The NIAID AIDS Vaccine Clinical Trials NetworkG J Gorse, J H Rogers, J E Perry, et al.
Clinical and Diagnostic Laboratory Immunology|July 1, 1996
Antibody to native human immunodeficiency virus type 1 envelope glycoproteins induced by IIIB and MN recombinant gp120 vaccines. The NIAID AIDS Vaccine Evaluation GroupG J Gorse, G B Patel, F K Newman, et al.
AIDS Research and Human Retroviruses|February 24, 1999
HIV-1MN recombinant glycoprotein 160 vaccine-induced cellular and humoral immunity boosted by HIV-1MN recombinant glycoprotein 120 vaccine. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation GroupG J Gorse, L Corey, G B Patel, et al.
Pageof 5